NDATOPICALCREAM
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MENTAX (butenafine hydrochloride) is a topical antifungal cream approved in 1996 for the treatment of tinea pedis (athlete's foot). It functions as a fungal cell membrane disruptor, though detailed mechanism of action data is not currently available. The product is a mature small-molecule therapeutic in the dermatology space.
$0.01BPart D
LOE ApproachingDeclining
low-single-digit % of topical antifungal market
Product is in advanced maturity with minimal recent spending; expect defensiveness rather than expansion in brand team headcount.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS
Started Jan 2019
42 enrolled
Tinea Pedis
Career Relevance
MENTAX roles are characterized by defensive commercial management and market-share preservation rather than growth or innovation. Professionals should expect limited team headcount, stable but unexciting compensation, and focus on generic-conversion mitigation strategies.
Brand Manager
Worked on MENTAX at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.